| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOMATERIALS.2006.04.029 |
| P8608 | Fatcat ID | release_63hpes5jjfcu7ov4gciq4zu4x4 |
| P698 | PubMed publication ID | 16725196 |
| P5875 | ResearchGate publication ID | 7058080 |
| P50 | author | Michael D. Buschmann | Q39680614 |
| P2093 | author name string | Nicolas Tran-Khanh | |
| Marc Lavertu | |||
| Stephane Méthot | |||
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 4815-4824 | |
| P577 | publication date | 2006-05-24 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation | |
| P478 | volume | 27 |
| Q26747664 | "The Good, the Bad and the Ugly" of Chitosans |
| Q30579701 | A dual-functionally modified chitosan derivative for efficient liver-targeted gene delivery |
| Q40181541 | Activation of tumor suppressor p53 gene expression by magnetic thymine-imprinted chitosan nanoparticles |
| Q38091630 | Advances in chitosan-based drug delivery vehicles |
| Q64977799 | Advances in delivery systems for doxorubicin. |
| Q37788222 | Advances in using chitosan-based nanoparticles forin vitroandin vivodrug and gene delivery |
| Q91656943 | Alveolar bone repair of rhesus monkeys by using BMP-2 gene and mesenchymal stem cells loaded three-dimensional printed bioglass scaffold |
| Q45746303 | Amiloride-enhanced gene transfection of octa-arginine functionalized calcium phosphate nanoparticles |
| Q33478275 | Bioengineered silk protein-based gene delivery systems |
| Q34978009 | Bone-Induced Chondroinduction in Sheep Jamshidi Biopsy Defects with and without Treatment by Subchondral Chitosan-Blood Implant: 1-Day, 3-Week, and 3-Month Repair |
| Q45877777 | Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis |
| Q37219130 | Branched polyethylenimine-grafted-carboxymethyl chitosan copolymer enhances the delivery of pDNA or siRNA in vitro and in vivo |
| Q34770009 | Cellular delivery of quantum dot-bound hybridization probe for detection of intracellular pre-microRNA using chitosan/poly(γ-glutamic acid) complex as a carrier |
| Q34465615 | Chitin and chitosan preparation from marine sources. Structure, properties and applications |
| Q28390546 | Chitosan coating of copper nanoparticles reduces in vitro toxicity and increases inflammation in the lung |
| Q42045871 | Chitosan combined with poly-L-arginine as efficient, safe, and serum-insensitive vehicle with RNase protection ability for siRNA delivery |
| Q38107047 | Chitosan for gene delivery and orthopedic tissue engineering applications. |
| Q47100559 | Chitosan immunomodulatory properties: perspectives on the impact of structural properties and dosage |
| Q58810730 | Chitosan in Non-Viral Gene Delivery: Role of Structure, Characterization Methods, and Insights in Cancer and Rare Diseases Therapies |
| Q39014313 | Chitosan nanoparticles as a potential nonviral gene delivery for HPV-16 E7 into mammalian cells. |
| Q45304943 | Chitosan rate of uptake in HEK293 cells is influenced by soluble versus microparticle state and enhanced by serum-induced cell metabolism and lactate-based media acidification. |
| Q39117006 | Chitosan tripolyphosphate (CS/TPP) nanoparticles: preparation, characterization and application for gene delivery in shrimp |
| Q40422521 | Chitosan-Mediated shRNA Knockdown of Cytosolic Alanine Aminotransferase Improves Hepatic Carbohydrate Metabolism |
| Q35083461 | Chitosan-graft-polyethylenimine/DNA nanoparticles as novel non-viral gene delivery vectors targeting osteoarthritis |
| Q46506214 | Chitosan-plasmid DNA nanoparticles encoding small hairpin RNA targeting MMP-3 and -13 to inhibit the expression of dedifferentiation related genes in expanded chondrocytes |
| Q45885233 | Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies |
| Q38311972 | Chitosan-sodium lauryl sulfate nanoparticles as a carrier system for the in vivo delivery of oral insulin. |
| Q46532493 | Chitosan-thiamine pyrophosphate as a novel carrier for siRNA delivery |
| Q40353194 | Chitosan-zein nano-in-microparticles capable of mediating in vivo transgene expression following oral delivery |
| Q34177543 | Chitosanase-based method for RNA isolation from cells transfected with chitosan/siRNA nanocomplexes for real-time RT-PCR in gene silencing |
| Q38122934 | Chitosans for delivery of nucleic acids. |
| Q36326103 | Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy. |
| Q37469872 | Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation |
| Q28659480 | Current progress in gene delivery technology based on chemical methods and nano-carriers |
| Q55072085 | Data on the experiments of temperature-sensitive hydrogels for pH-sensitive drug release and the characterizations of materials. |
| Q36756873 | Dense chitosan surgical membranes produced by a coincident compression-dehydration process |
| Q39588291 | Diol glycidyl ether-bridged cyclens: preparation and their applications in gene delivery |
| Q90713745 | Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection |
| Q45868438 | Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes |
| Q92210546 | Effects of Chain Length of Chitosan Oligosaccharides on Solution Properties and Complexation with siRNA |
| Q48020807 | Effects of tripolyphosphate on cellular uptake and RNA interference efficiency of chitosan-based nanoparticles in Raw 264.7 macrophages. |
| Q92351308 | Efficiency of Chitosan/Hyaluronan-Based mRNA Delivery Systems In Vitro: Influence of Composition and Structure |
| Q35864390 | Efficient Nonviral Gene Therapy Using Folate-Targeted Chitosan-DNA Nanoparticles In Vitro |
| Q80766949 | Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly |
| Q42462258 | Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: effect of pH and serum |
| Q27309096 | Enhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan/DNA complexes |
| Q38340017 | Galactosyl conjugated N-succinyl-chitosan-graft-polyethylenimine for targeting gene transfer |
| Q34443707 | Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy |
| Q30932494 | Grafting chitosan with polyethylenimine in an ionic liquid for efficient gene delivery |
| Q38053216 | Green synthesis approach: extraction of chitosan from fungus mycelia |
| Q42159274 | Histidine-rich stabilized polyplexes for cMet-directed tumor-targeted gene transfer |
| Q36201940 | Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. |
| Q34496985 | Hydrodynamic delivery of chitosan-folate-DNA nanoparticles in rats with adjuvant-induced arthritis |
| Q33549485 | Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel |
| Q47718581 | Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes. |
| Q39455958 | Imidazole-grafted chitosan-mediated gene delivery: in vitro study on transfection, intracellular trafficking and degradation |
| Q39029692 | Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification. |
| Q40695620 | Increased in vitro Cell Proliferation by Chitosan/pGM-CSF Complexes |
| Q35119565 | Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles. |
| Q39680573 | Intracellular trafficking and decondensation kinetics of chitosan-pDNA polyplexes |
| Q39749630 | Linear cyclen-based polyamine as a novel and efficient reagent in gene delivery |
| Q36437187 | Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies |
| Q35846845 | Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery. |
| Q57341891 | Materials Based on Chitin and Chitosan |
| Q27001558 | Micelle-like nanoparticles as carriers for DNA and siRNA |
| Q33895017 | Molecular dynamics study on the mechanism of polynucleotide encapsulation by chitosan |
| Q33612179 | Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy |
| Q26780430 | Nanodelivery Systems as New Tools for Immunostimulant or Vaccine Administration: Targeting the Fish Immune System |
| Q28485257 | Nanoparticle mediated P-glycoprotein silencing for improved drug delivery across the blood-brain barrier: a siRNA-chitosan approach |
| Q37004107 | Nanoparticulate systems for polynucleotide delivery. |
| Q28077047 | Nanotechnology: A Valuable Strategy to Improve Bacteriocin Formulations |
| Q47771787 | On-Chip Preparation of Streptokinase Entrapped in Chitosan Nanoparticles Used in Thrombolytic Therapy Potentially |
| Q40045947 | Optimized PEI-based Transfection Method for Transient Transfection and Lentiviral Production |
| Q47980720 | Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. |
| Q53278213 | Performance of PRP associated with porous chitosan as a composite scaffold for regenerative medicine. |
| Q92192658 | Physicochemical and Colligative Investigation of α (Shrimp Shell)- and β (Squid Pen)-Chitosan Membranes: Concentration-Gradient-Driven Water Flux and Ion Transport for Salinity Gradient Power and Separation Process Operations |
| Q30663038 | Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells |
| Q42155678 | Physicochemical properties of polymers: An important system to overcome the cell barriers in gene transfection. |
| Q38693411 | Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen |
| Q39133992 | Polyethyleneglycol crosslinked N-(2-hydroxyethyl)-polyethylenimine nanoparticles as efficient non-viral vectors for DNA and siRNA delivery in vitro and in vivo |
| Q36316919 | Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers |
| Q37920729 | Polymeric vectors for ocular gene delivery. |
| Q50347968 | Polysaccharides for the Delivery of Antitumor Drugs |
| Q27310684 | Porous chitosan scaffolds with embedded hyaluronic acid/chitosan/plasmid-DNA nanoparticles encoding TGF-β1 induce DNA controlled release, transfected chondrocytes, and promoted cell proliferation |
| Q41947989 | Preparation and nanoencapsulation of l-asparaginase II in chitosan-tripolyphosphate nanoparticles and in vitro release study |
| Q40017046 | Preparation of Concentrated Chitosan/DNA Nanoparticle Formulations by Lyophilization for Gene Delivery at Clinically Relevant Dosages |
| Q26766552 | Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery |
| Q40027542 | Quantitative comparison of intracellular unpacking kinetics of polyplexes by a model constructed from quantum dot-FRET. |
| Q34956317 | Recent advances of chitosan nanoparticles as drug carriers |
| Q46634133 | Regioselective thioacetylation of chitosan end-groups for nanoparticle gene delivery systems |
| Q43035472 | Regulated expression of microinjected DNA in adult Aedes aegypti mosquitoes |
| Q58810735 | SYBR Gold Fluorescence Quenching is a Sensitive Probe of Chitosan-microRNA Interactions |
| Q38916305 | Shell Biorefinery: Dream or Reality? |
| Q47394718 | Stabilisation of SWNTs by alkyl-sulfate chitosan derivatives of different molecular weight: towards the preparation of hybrids with anticoagulant properties |
| Q50153578 | Stability and bioactivity of chitosan as a transfection agent in primary human cell cultures: A case for chitosan-only controls |
| Q41914673 | Structure Dependence of Lysosomal Transit of Chitosan-Based Polyplexes for Gene Delivery |
| Q34550026 | Subchondral pre-solidified chitosan/blood implants elicit reproducible early osteochondral wound-repair responses including neutrophil and stromal cell chemotaxis, bone resorption and repair, enhanced repair tissue integration and delayed matrix dep |
| Q37584464 | Surface-modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer |
| Q50230622 | Targeted DNA delivery to cancer cells using a biotinylated chitosan carrier. |
| Q38264691 | Targeted delivery systems for biological therapies of inflammatory diseases |
| Q53111022 | Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticles. |
| Q29248502 | The Absence of CpG in Plasmid DNA–Chitosan Polyplexes Enhances Transfection Efficiencies and Reduces Inflammatory Responses in Murine Lungs |
| Q45863464 | The influence of chitosan valence on the complexation and transfection of DNA: The weaker the DNA–chitosan binding the higher the transfection efficiency |
| Q42784167 | The novel albumin-chitosan core-shell nanoparticles for gene delivery: preparation, optimization and cell uptake investigation. |
| Q39747894 | Transfection efficiency of depolymerized chitosan and epidermal growth factor conjugated to chitosan-DNA polyplexes |
| Q37999460 | Understanding nonviral nucleic acid delivery with quantum dot-FRET nanosensors |
| Q36869459 | Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages |
| Q41991594 | Versatility of chitosan/BmNPV bacmid DNA nanocomplex as transfection reagent of recombinant protein expression in silkworm larvae |
| Q47815925 | iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery. |
| Q37807993 | siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis. |
Search more.